Kenechukwu Ndubisi Mezue, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Pressure | 9 | 2018 | 8554 | 1.010 |
Why?
|
Heart Failure, Diastolic | 1 | 2023 | 69 | 0.850 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2022 | 53 | 0.830 |
Why?
|
Antihypertensive Agents | 6 | 2018 | 2046 | 0.820 |
Why?
|
Cardiovascular System | 2 | 2018 | 832 | 0.710 |
Why?
|
Lighting | 1 | 2022 | 231 | 0.710 |
Why?
|
Cardiovascular Diseases | 8 | 2023 | 15165 | 0.710 |
Why?
|
Resource Allocation | 1 | 2020 | 341 | 0.630 |
Why?
|
Health Care Rationing | 1 | 2020 | 437 | 0.580 |
Why?
|
Hypertension | 8 | 2018 | 8480 | 0.580 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2022 | 554 | 0.570 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.460 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2022 | 2016 | 0.460 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1411 | 0.420 |
Why?
|
Pyridones | 1 | 2017 | 712 | 0.410 |
Why?
|
Pacemaker, Artificial | 1 | 2017 | 816 | 0.400 |
Why?
|
Diet, Sodium-Restricted | 1 | 2013 | 287 | 0.400 |
Why?
|
Blood Pressure Determination | 4 | 2018 | 634 | 0.380 |
Why?
|
Sodium, Dietary | 1 | 2013 | 418 | 0.350 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2019 | 2208 | 0.350 |
Why?
|
Heart Failure | 5 | 2023 | 10900 | 0.290 |
Why?
|
Acute Kidney Injury | 4 | 2021 | 1972 | 0.280 |
Why?
|
Pyrazoles | 1 | 2017 | 1972 | 0.280 |
Why?
|
Medication Adherence | 1 | 2017 | 2063 | 0.270 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3133 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.260 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 2 | 2017 | 236 | 0.250 |
Why?
|
Circadian Rhythm | 1 | 2016 | 2624 | 0.250 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2017 | 1813 | 0.230 |
Why?
|
Thirst | 1 | 2022 | 38 | 0.210 |
Why?
|
Stroke | 4 | 2018 | 9981 | 0.210 |
Why?
|
Noise, Transportation | 1 | 2022 | 50 | 0.210 |
Why?
|
Coronary Disease | 1 | 2017 | 6077 | 0.210 |
Why?
|
Pandemics | 3 | 2020 | 8388 | 0.200 |
Why?
|
Renal Insufficiency | 2 | 2018 | 804 | 0.200 |
Why?
|
Risk Factors | 13 | 2023 | 72290 | 0.200 |
Why?
|
Anticoagulants | 1 | 2017 | 4599 | 0.200 |
Why?
|
Vena Cava, Superior | 1 | 2022 | 193 | 0.200 |
Why?
|
Rheumatic Heart Disease | 1 | 2023 | 177 | 0.200 |
Why?
|
Humans | 39 | 2023 | 744343 | 0.170 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2023 | 1155 | 0.170 |
Why?
|
Ventricular Function, Right | 2 | 2019 | 591 | 0.160 |
Why?
|
Africa South of the Sahara | 1 | 2020 | 724 | 0.150 |
Why?
|
Echocardiography | 3 | 2023 | 5102 | 0.150 |
Why?
|
Diuretics | 2 | 2017 | 592 | 0.150 |
Why?
|
Causality | 1 | 2023 | 1275 | 0.150 |
Why?
|
Directly Observed Therapy | 1 | 2017 | 137 | 0.140 |
Why?
|
Ethanol | 1 | 2023 | 1342 | 0.140 |
Why?
|
Hypertension, Pulmonary | 2 | 2019 | 1537 | 0.140 |
Why?
|
Iloprost | 1 | 2015 | 29 | 0.140 |
Why?
|
Caribbean Region | 1 | 2016 | 194 | 0.140 |
Why?
|
Renin-Angiotensin System | 1 | 2020 | 759 | 0.130 |
Why?
|
Kidney Function Tests | 1 | 2017 | 684 | 0.130 |
Why?
|
Neurotransmitter Agents | 1 | 2019 | 647 | 0.130 |
Why?
|
Radiopharmaceuticals | 2 | 2022 | 2645 | 0.130 |
Why?
|
Molecular Imaging | 1 | 2022 | 828 | 0.130 |
Why?
|
Aortic Valve Stenosis | 2 | 2017 | 1965 | 0.130 |
Why?
|
Systole | 1 | 2017 | 958 | 0.130 |
Why?
|
Epoprostenol | 1 | 2015 | 254 | 0.120 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2020 | 531 | 0.120 |
Why?
|
Hyponatremia | 1 | 2017 | 298 | 0.120 |
Why?
|
Glomerular Filtration Rate | 2 | 2018 | 2170 | 0.120 |
Why?
|
Embolism | 1 | 2017 | 408 | 0.110 |
Why?
|
Kidney | 2 | 2019 | 7186 | 0.110 |
Why?
|
Food Industry | 1 | 2013 | 68 | 0.110 |
Why?
|
Environmental Pollutants | 1 | 2022 | 1179 | 0.110 |
Why?
|
Calcium Channel Blockers | 1 | 2015 | 690 | 0.100 |
Why?
|
Pulmonary Artery | 1 | 2020 | 1912 | 0.100 |
Why?
|
Hemodynamics | 2 | 2019 | 4199 | 0.100 |
Why?
|
Social Class | 1 | 2020 | 1999 | 0.100 |
Why?
|
Bacteremia | 1 | 2018 | 962 | 0.100 |
Why?
|
Vasodilator Agents | 1 | 2015 | 977 | 0.100 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1772 | 0.100 |
Why?
|
Alcohol Drinking | 1 | 2023 | 3966 | 0.090 |
Why?
|
Nigeria | 1 | 2013 | 733 | 0.090 |
Why?
|
Adenosine | 1 | 2015 | 825 | 0.090 |
Why?
|
Predictive Value of Tests | 3 | 2022 | 15076 | 0.090 |
Why?
|
Risk Assessment | 3 | 2022 | 23338 | 0.090 |
Why?
|
Secondary Prevention | 1 | 2016 | 1530 | 0.090 |
Why?
|
Heart | 2 | 2020 | 4467 | 0.080 |
Why?
|
Administration, Oral | 1 | 2017 | 3913 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1797 | 0.080 |
Why?
|
Middle Aged | 12 | 2023 | 213383 | 0.080 |
Why?
|
Regression Analysis | 1 | 2018 | 6459 | 0.080 |
Why?
|
Air Pollutants | 1 | 2022 | 2817 | 0.080 |
Why?
|
Heart-Assist Devices | 1 | 2018 | 1194 | 0.080 |
Why?
|
Genetic Variation | 1 | 2023 | 6544 | 0.080 |
Why?
|
Heart Neoplasms | 1 | 2010 | 374 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6538 | 0.070 |
Why?
|
Coronary Artery Disease | 2 | 2017 | 6487 | 0.070 |
Why?
|
Male | 12 | 2023 | 350118 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2018 | 3821 | 0.070 |
Why?
|
Female | 12 | 2023 | 380194 | 0.070 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 6234 | 0.070 |
Why?
|
Graft Rejection | 1 | 2019 | 4397 | 0.070 |
Why?
|
Hemangioma | 1 | 2010 | 738 | 0.060 |
Why?
|
Prevalence | 3 | 2023 | 15226 | 0.060 |
Why?
|
Hemorrhage | 1 | 2017 | 3461 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10252 | 0.060 |
Why?
|
Heart Rate | 1 | 2016 | 4091 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2019 | 4251 | 0.060 |
Why?
|
Time Factors | 4 | 2018 | 40075 | 0.060 |
Why?
|
Ventricular Function, Left | 1 | 2016 | 3670 | 0.060 |
Why?
|
Aged | 8 | 2021 | 163280 | 0.050 |
Why?
|
Income | 2 | 2023 | 1913 | 0.050 |
Why?
|
Tachycardia, Ventricular | 1 | 2010 | 1273 | 0.050 |
Why?
|
Health Promotion | 1 | 2013 | 2205 | 0.050 |
Why?
|
Periodontium | 1 | 2021 | 99 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 5391 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5751 | 0.050 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2020 | 86 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2017 | 57776 | 0.040 |
Why?
|
United States | 2 | 2023 | 69872 | 0.040 |
Why?
|
Catheters | 1 | 2020 | 425 | 0.040 |
Why?
|
Morbidity | 1 | 2023 | 1769 | 0.040 |
Why?
|
Expert Testimony | 1 | 2019 | 356 | 0.040 |
Why?
|
Inhalation | 1 | 2015 | 143 | 0.030 |
Why?
|
Diet | 1 | 2013 | 7939 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2021 | 77449 | 0.030 |
Why?
|
Catheter-Related Infections | 1 | 2018 | 252 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2016 | 11727 | 0.030 |
Why?
|
American Heart Association | 1 | 2019 | 1056 | 0.030 |
Why?
|
Prognosis | 3 | 2019 | 29063 | 0.030 |
Why?
|
Office Visits | 1 | 2017 | 598 | 0.030 |
Why?
|
Pregnancy Outcome | 1 | 2023 | 2795 | 0.030 |
Why?
|
Bronchodilator Agents | 1 | 2015 | 502 | 0.030 |
Why?
|
Inflammation | 2 | 2022 | 10638 | 0.030 |
Why?
|
Troponin I | 1 | 2016 | 619 | 0.030 |
Why?
|
Vasodilation | 1 | 2015 | 944 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2017 | 63114 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2015 | 500 | 0.020 |
Why?
|
Particulate Matter | 1 | 2022 | 2530 | 0.020 |
Why?
|
Drug Resistance | 1 | 2016 | 1609 | 0.020 |
Why?
|
Dyspnea | 1 | 2017 | 1303 | 0.020 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2017 | 1873 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2864 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1405 | 0.020 |
Why?
|
Poverty | 1 | 2020 | 2660 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5317 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2022 | 4234 | 0.020 |
Why?
|
Education, Medical | 1 | 2019 | 1721 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2015 | 2132 | 0.020 |
Why?
|
Stroke Volume | 1 | 2018 | 5007 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39050 | 0.020 |
Why?
|
Acute Disease | 1 | 2016 | 7149 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9687 | 0.020 |
Why?
|
Contrast Media | 1 | 2017 | 5300 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29144 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 20947 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 40561 | 0.010 |
Why?
|
Adult | 1 | 2021 | 214055 | 0.000 |
Why?
|